Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

(2020) Aiping Wu et al.   Cell Host & Microbe

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

(2020) B. Coutard et al.   ANTIVIRAL RESEARCH

From SARS to MERS, Thrusting Coronaviruses into the Spotlight

(2019) Zhiqi Song et al.   Viruses-Basel

Hypoxic regulation of angiotensin‐converting enzyme 2 and Mas receptor in human CD34 + cells

(2019) Shrinidh Joshi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins

(2019) Elisabeth Braun et al.   Cell Reports

Structure, Function, and Evolution of Coronavirus Spike Proteins

(2016) Fang Li   Annual Review of Virology

The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients

(2015) Morgan Hakki et al.   JOURNAL OF CLINICAL VIROLOGY

Regulation of HIF-1 alpha by the proprotein convertases furin and PC7 in human squamous carcinoma cells

(2014) Jian Fu et al.   MOLECULAR CARCINOGENESIS

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

(2013) Xing-Yi Ge et al.   NATURE

SARS-CoV Regulates Immune Function-Related Gene Expression in Human Monocytic Cells

(2012) Wanchung Hu et al.   VIRAL IMMUNOLOGY